financetom
Business
financetom
/
Business
/
Campbell's Tempers Fiscal 2025 Outlook After Second-Quarter Sales Miss
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Campbell's Tempers Fiscal 2025 Outlook After Second-Quarter Sales Miss
Mar 5, 2025 7:33 AM

10:01 AM EST, 03/05/2025 (MT Newswires) -- Campbell's (CPB), formerly known as Campbell Soup, on Wednesday reported fiscal second-quarter revenue that fell short of analysts' expectations, while the consumer packaged food firm cut its 2025 outlook.

Net sales rose to $2.69 billion during the three months ended Jan. 26 from $2.46 billion a year earlier, but trailed the FactSet-polled consensus of $2.74 billion. The 9% increase was driven by the Sovos Brands acquisition. Organic net sales decreased 2% due to "net price realization with flat volume/mix," Campbell's said.

Adjusted earnings dropped to $0.74 per share from $0.80 per share a year earlier, but beat the consensus of $0.72.

"Given the softness in some of our snacking categories, the anticipated sequential top-line improvement did not materialize during the quarter, and we now have a more muted second half expectation," Chief Executive Mick Beekhuizen said in a statement.

The company lowered its adjusted EPS guidance to between $2.95 and $3.05 for 2025 from its prior estimate of $3.12 to $3.22. Analysts are modeling for $3.12.

Full-year net sales growth is now expected at 6% to 8%, compared with the previous outlook of 9% to 11%. Organic sales are projected to be flat to down 2%, instead of growing as much as 2% under the prior guidance.

Campbell's shares dropped 2.6% intraday.

"We remain confident in our ability to successfully navigate the current consumer landscape with our portfolio of advantaged leadership brands, talented team and track record of execution," Beekhuizen said. "We have a strong foundation to deliver long-term sustainable, profitable growth and shareholder returns."

Price: 38.98, Change: -1.35, Percent Change: -3.35

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Platinum Equity's Ingram Micro seeks up to $5.4 bln valuation in US IPO
Platinum Equity's Ingram Micro seeks up to $5.4 bln valuation in US IPO
Oct 17, 2024
* Ingram, PE firm seek to raise as much as $428 mln * Platinum Equity will remain controlling shareholder post-IPO * Ingram set to go public again, 28 years after initial NYSE debut (Adds background on company and IPO details in paragraphs 4-12) Oct 15 (Reuters) - Ingram Micro is targeting a valuation of up to $5.42 billion in its...
Johnson & Johnson Reports Positive Phase 2/3 Study Results for Nipocalimab in Myasthenia Gravis Adolescents
Johnson & Johnson Reports Positive Phase 2/3 Study Results for Nipocalimab in Myasthenia Gravis Adolescents
Oct 17, 2024
08:59 AM EDT, 10/15/2024 (MT Newswires) -- Johnson & Johnson ( JNJ ) said Tuesday its phase 2/3 Vibrance-MG study of nipocalimab in adolescents with generalized myasthenia gravis met its primary endpoint by achieving sustained disease control. Treatment with nipocalimab plus standard of care reduced immunoglobulin G levels by 69% over 24 weeks, the company said. The combination treatment also...
Knight Therapeutics Anti-Cancer Treatment Gains Approval in Mexico
Knight Therapeutics Anti-Cancer Treatment Gains Approval in Mexico
Oct 17, 2024
08:57 AM EDT, 10/15/2024 (MT Newswires) -- Knight Therapeutics ( KHTRF ) on Tuesday said its Mexican affiliate has obtained regulatory approval for Minjuvi (tafasitamab) for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) that aren't eligible for autologous stem cell transplantation. The treatment is expected to launch in the first half of next...
S&P Global Names Eric Aboaf CFO
S&P Global Names Eric Aboaf CFO
Oct 17, 2024
08:57 AM EDT, 10/15/2024 (MT Newswires) -- S&P Global ( SPGI ) said Tuesday that it has named Eric Aboaf as its chief financial officer, effective February. Aboaf was most recently the CFO of State Street (STT). Price: 528.96, Change: +1.44, Percent Change: +0.27 ...
Copyright 2023-2025 - www.financetom.com All Rights Reserved